resources

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM

BSE: 500420

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

4,896.50-108.5 (-2.17%)

21 Aug, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Torrent Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Sept Dec	Mar Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept	Mar
Conference Calls	—	—	—	—	—	—	—	—	—	30May 5Aug 28Oct	1Feb 3Jun 11Aug 26Oct	7Feb 30May 29Jul 30Oct	31Jan 23May 31Jul 13Nov	20Feb 27May 4Aug
Presentations	—	—	—	—	—	—	—	—	8Feb 18May 27Jul 26Oct	25Jan 25May 29Jul 27Sept 21Oct	25Jan 30May 7Aug 23Oct	2Feb 24May 23Jul 25Oct	24Jan 20May 30Jun 28Jul 7Nov	13Feb 22May

Corporate Announcements and Regulatory Filings

Torrent Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Analyst / Investor Meet11 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
General11 Aug 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating
ESG Rating
Newspaper Publication6 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for completion of dispatch of Postal Ballot Notice
Postal Ballot5 Aug 2026
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot
Analyst / Investor Meet4 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2026
Cessation1 Aug 2026
Announcement under Regulation 30 (LODR)-Cessation
Intimation of Cessation of Director of the Company
Analyst / Investor Meet30 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Recording Link of Analyst call - Q1 Results
Change in Management30 Jul 2026
Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior Management Personnel
Outcome of Board Meeting30 Jul 2026
Board Meeting Outcome for Outcome Of Board Meeting Dated 30-Jul-26
Outcome of Board Meeting dated 30-Jul-26
Change in Management28 Jul 2026
Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Shanti Ekambaram as an Independent Director of the Company
General27 Jul 2026
Receipt Of Final Listing And Trading Approval For Equity Shares Of The Company Issued And Allotted In Terms Of Scheme Of Amalgamation
Receipt of final listing and Trading approval for Equity shares of the Company issued and allotted in terms of Scheme of Amalgamation
General20 Jul 2026
Allotment Of 4,19,22,416 Fully Paid-Up Equity Shares Of The Company To The Eligible Shareholders Of J. B. Chemicals & Pharmaceuticals Limited As On The Record Date I.E. 17Th July, 2026, In Terms Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders
Allotment of Equity shares of the Company to eligible shareholders of J B Chemicals as on Record Date in terms of Scheme of Amalgamation
General17 Jul 2026
Dissolution Of Wholly Owned Subsidiary (WOS)
Disclosure pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 - Dissolution of Wholly Owned Subsidiary (WOS)
General17 Jul 2026
ESG Rating
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - ESG Rating
Analyst / Investor Meet17 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Post Quarterly Financial Result Conference call with investors / analyst
Board Meeting16 Jul 2026
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results (With Limited Review) For The Quarter Ended On 30-Jun-26.
Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve to consider and approve ....
Press Release / Media Release9 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release
Newspaper Publication8 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement in respect of special window for transfer and dematerialisation request of physical shares
Amendments to Memorandum & Articles of Association8 Jul 2026
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Amendment to Memorandum of Association
General8 Jul 2026
Intimation Of Effective Date Of Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders
Intimation of Effective Date of Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders

Frequently Asked Questions

Where can I download the annual report of Torrent Pharmaceuticals Ltd.?

Annual reports of Torrent Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Torrent Pharmaceuticals Ltd.?

Quarterly earnings results and presentations of Torrent Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Torrent Pharmaceuticals Ltd. publish earnings call transcripts?

Earnings call transcripts of Torrent Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Torrent Pharmaceuticals Ltd.?

Investor presentations and annual day presentations of Torrent Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Torrent Pharmaceuticals Ltd.?

Corporate announcements and regulatory filings of Torrent Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Torrent Pharmaceuticals Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Torrent Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Torrent Pharmaceuticals Ltd.?

The ISIN (International Securities Identification Number) of Torrent Pharmaceuticals Ltd. is INE685A01028. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Torrent Pharmaceuticals Ltd. listed?

Torrent Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is TORNTPHARM and the BSE code is -.

Where can I find the shareholding pattern of Torrent Pharmaceuticals Ltd.?

The quarterly shareholding pattern of Torrent Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Torrent Pharmaceuticals Ltd. on Sharpely?

Share price data for Torrent Pharmaceuticals Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.